A new treatment for Hodgkin lymphoma has been recommended for routine use on the NHS. Around 800 people with the advanced ...

NICE recommended Pfizer's Adcetris for NHS use in advanced Hodgkin lymphoma, citing strong trial data and a new discount agreement with Takeda.

From today, adults with advanced Hodgkin lymphoma have access to a new treatment, after we recommended brentuximab vedotin (brand name Adcetris) in combination with other therapies for routine NHS use ...

Takeda's Adcetris has become the first drug recommended for routine NHS use as a treatment for previously untreated ...

A new treatment for Hodgkin lymphoma has been recommended for routine use on the NHS. Around 800 people with the advanced ...

The National Institute for Health and Care Excellence (NICE) has recommended brentuximab vedotin combined with doxorubicin, ...

It is estimated that about 800 people with Hodgkin lymphoma could benefit from the decision by the National Institute for ...

This revolutionary approach has given hope to patients who previously had limited or no options, particularly those battling ...

Dave Coulier, best known for his role as Joey Gladstone on the beloved sitcom Full House, has been declared cancer-free just ...

Patients on Adcetris and chemo had better progression-free and overall survival after six years of follow-up compared to those on chemo only.